/term/net-income-continuing-operations/XSWX:CLS1 McKesson Europe AG (XSWX:CLS1) Net Income (Continuing Opera
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (XSWX:CLS1) » Definitions » Net Income (Continuing Operations)

McKesson Europe AG (XSWX:CLS1) Net Income (Continuing Operations) : CHF-50.56 Mil (TTM As of Mar. 2022)


View and export this data going back to 2014. Start your Free Trial

What is McKesson Europe AG Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. McKesson Europe AG's Net Income (Continuing Operations) for the six months ended in Mar. 2022 was CHF-50.56 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2022 was CHF-50.56 Mil.


McKesson Europe AG Net Income (Continuing Operations) Historical Data

The historical data trend for McKesson Europe AG's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Net Income (Continuing Operations) Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -349.74 -47.93 -70.07 6.86 -50.56

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -349.74 -47.93 -70.07 6.86 -50.56

McKesson Europe AG Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2022 was CHF-50.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McKesson Europe AG  (XSWX:CLS1) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


McKesson Europe AG Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (XSWX:CLS1) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (XSWX:CLS1) Headlines

No Headlines